Filing Details

Accession Number:
0001213900-22-040369
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-19 17:30:27
Reporting Period:
2022-07-15
Accepted Time:
2022-07-19 17:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1913009 Kara Cannon C/O Enzo Biochem, Inc.
81 Executive Blvd, Suite 3
Farmingdale NY 11735
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2022-07-15 2,500 $2.42 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 22,614 Indirect 401k